The temporary mechanical circulatory support device market size has grown strongly in recent years. It will grow from $2.66 billion in 2025 to $2.9 billion in 2026 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to limited availability of temporary mcs devices, reliance on invasive open-heart procedures, high mortality rates from cardiogenic shock, growing demand for acute cardiac care, lack of portable and wearable solutions.
The temporary mechanical circulatory support device market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to technological advancements in biomimetic and hybrid devices, increasing adoption of minimally invasive mcs, rising cardiac surgery volumes, expansion of outpatient cardiac centers, integration of digital monitoring and smart hemodynamic management. Major trends in the forecast period include rising adoption of percutaneous ventricular assist devices, increased use of extracorporeal membrane oxygenation (ecmo), growth in high-risk cardiac procedures, expansion of bridge-to-transplant and bridge-to-recovery applications, focus on minimally invasive and portable mcs devices.
The rising incidence of cardiovascular diseases is expected to drive the growth of the temporary mechanical circulatory support device market in the coming years. Cardiovascular diseases (CVD) encompass a range of disorders affecting the heart and blood vessels, leading to conditions such as heart attacks, strokes, and hypertension. The increase in cardiovascular diseases is largely driven by aging populations, as older age elevates the risk of heart and vascular conditions. Temporary mechanical circulatory support devices assist patients with CVD by providing short-term support to heart function and improving blood flow during critical situations such as heart failure or cardiogenic shock. For example, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England - approximately 4.4% of those aged 18 and above - had a GP-recorded diagnosis of chronic kidney disease (CKD), up from 2.09 million cases the previous year. Therefore, the increasing incidence of cardiovascular diseases is fueling growth in the temporary mechanical circulatory support device market.
Major players in the temporary mechanical circulatory support (tMCS) device market are entering strategic partnerships to advance innovative technologies. For example, in November 2025, VenstraMedical, an Australia-based cardiovascular medical device company, partnered with Highcroft Capital, a US-based venture capital firm, securing strategic investment to accelerate the development of its next-generation percutaneous ventricular assist device (pVAD). This low-profile, catheter-based pump is engineered to provide full ventricular unloading and hemodynamic support for patients in cardiogenic shock or undergoing high-risk coronary interventions. Protected by multiple patents, the device allows minimally invasive insertion and can deliver up to 7 liters per minute of cardiac output. The investment underscores VenstraMedical’s goal to transform temporary mechanical circulatory support in a market valued at over $2 billion, with plans to progress toward clinical trials and commercialization.
In February 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Cardiovascular Systems, Inc. (CSI) for an undisclosed sum. Through this acquisition, Abbott aims to expand and diversify its vascular-device portfolio by incorporating CSI’s specialized atherectomy technology, enhancing its treatment options for complex peripheral and coronary artery disease. CSI, also based in the US, is a medical device company that develops temporary mechanical circulatory support devices.
Major companies operating in the temporary mechanical circulatory support device market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Procyrion Inc., CardioBridge GmbH, Abiomed Inc., Berlin Heart GmbH, Thoratec Corporation, PulseCath BV, TandemLife Inc., SynCardia Systems LLC, CardiacAssist Inc., Xenios AG, Nihon Kohden Corporation, Eurosets Srl, Senko Medical Instrument Manufacturing Co Ltd, Nipro Medical Corporation, Calon Cardio‑Technology Ltd., Windmill Cardiovascular Systems Inc.
North America was the largest region in the temporary mechanical circulatory support device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the temporary mechanical circulatory support device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the temporary mechanical circulatory support device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the temporary mechanical circulatory support device market by increasing the cost of imported components such as mechanical pumps, biomimetic devices, and advanced sensors. Segments like biventricular support devices and novel wearable devices are particularly impacted, with North America and Asia-Pacific regions such as China and India facing notable import duties. This has resulted in higher production costs and potential delays in device availability. On the positive side, tariffs have encouraged local manufacturing, innovation in cost-efficient device designs, and investment in domestic production capabilities.
The temporary mechanical circulatory support device market research report is one of a series of new reports that provides temporary mechanical circulatory support device market statistics, including temporary mechanical circulatory support device industry global market size, regional shares, competitors with a temporary mechanical circulatory support device market share, detailed temporary mechanical circulatory support device market segments, market trends and opportunities, and any further data you may need to thrive in the temporary mechanical circulatory support device industry. This temporary mechanical circulatory support device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A temporary mechanical circulatory support (MCS) device is a specialized medical tool designed to provide short-term assistance to the heart’s pumping function in patients with acute cardiac dysfunction or failure. It mechanically enhances blood flow and stabilizes hemodynamics until recovery, transplantation, or a more permanent intervention can be undertaken. These devices are primarily used in critical care settings to support patients during high-risk cardiac procedures, manage cardiogenic shock, or serve as a bridge to heart transplantation or durable ventricular assist device implantation.
The main categories of temporary mechanical circulatory support devices include left ventricular support devices, right ventricular support devices, and biventricular support devices. Left ventricular support devices assist or replace the pumping function of the left ventricle to maintain adequate blood flow in patients with heart failure. These devices utilize various technologies such as pneumatic systems, mechanical pumps, biomimetic devices, hybrid systems, and emerging wearable solutions. Their applications include managing cardiogenic shock, bridging to transplantation, bridging to recovery, supporting high-risk cardiac procedures, and others. Key end-users comprise hospitals, cardiac surgery centers, outpatient surgical facilities, research and academic institutions, and other healthcare organizations.
The temporary mechanical circulatory support device market consists of sales of intra-aortic balloon pump, extracorporeal membrane oxygenation device, percutaneous ventricular assist device, and centrifugal pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The temporary mechanical circulatory support device market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to technological advancements in biomimetic and hybrid devices, increasing adoption of minimally invasive mcs, rising cardiac surgery volumes, expansion of outpatient cardiac centers, integration of digital monitoring and smart hemodynamic management. Major trends in the forecast period include rising adoption of percutaneous ventricular assist devices, increased use of extracorporeal membrane oxygenation (ecmo), growth in high-risk cardiac procedures, expansion of bridge-to-transplant and bridge-to-recovery applications, focus on minimally invasive and portable mcs devices.
The rising incidence of cardiovascular diseases is expected to drive the growth of the temporary mechanical circulatory support device market in the coming years. Cardiovascular diseases (CVD) encompass a range of disorders affecting the heart and blood vessels, leading to conditions such as heart attacks, strokes, and hypertension. The increase in cardiovascular diseases is largely driven by aging populations, as older age elevates the risk of heart and vascular conditions. Temporary mechanical circulatory support devices assist patients with CVD by providing short-term support to heart function and improving blood flow during critical situations such as heart failure or cardiogenic shock. For example, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England - approximately 4.4% of those aged 18 and above - had a GP-recorded diagnosis of chronic kidney disease (CKD), up from 2.09 million cases the previous year. Therefore, the increasing incidence of cardiovascular diseases is fueling growth in the temporary mechanical circulatory support device market.
Major players in the temporary mechanical circulatory support (tMCS) device market are entering strategic partnerships to advance innovative technologies. For example, in November 2025, VenstraMedical, an Australia-based cardiovascular medical device company, partnered with Highcroft Capital, a US-based venture capital firm, securing strategic investment to accelerate the development of its next-generation percutaneous ventricular assist device (pVAD). This low-profile, catheter-based pump is engineered to provide full ventricular unloading and hemodynamic support for patients in cardiogenic shock or undergoing high-risk coronary interventions. Protected by multiple patents, the device allows minimally invasive insertion and can deliver up to 7 liters per minute of cardiac output. The investment underscores VenstraMedical’s goal to transform temporary mechanical circulatory support in a market valued at over $2 billion, with plans to progress toward clinical trials and commercialization.
In February 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Cardiovascular Systems, Inc. (CSI) for an undisclosed sum. Through this acquisition, Abbott aims to expand and diversify its vascular-device portfolio by incorporating CSI’s specialized atherectomy technology, enhancing its treatment options for complex peripheral and coronary artery disease. CSI, also based in the US, is a medical device company that develops temporary mechanical circulatory support devices.
Major companies operating in the temporary mechanical circulatory support device market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Procyrion Inc., CardioBridge GmbH, Abiomed Inc., Berlin Heart GmbH, Thoratec Corporation, PulseCath BV, TandemLife Inc., SynCardia Systems LLC, CardiacAssist Inc., Xenios AG, Nihon Kohden Corporation, Eurosets Srl, Senko Medical Instrument Manufacturing Co Ltd, Nipro Medical Corporation, Calon Cardio‑Technology Ltd., Windmill Cardiovascular Systems Inc.
North America was the largest region in the temporary mechanical circulatory support device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the temporary mechanical circulatory support device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the temporary mechanical circulatory support device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the temporary mechanical circulatory support device market by increasing the cost of imported components such as mechanical pumps, biomimetic devices, and advanced sensors. Segments like biventricular support devices and novel wearable devices are particularly impacted, with North America and Asia-Pacific regions such as China and India facing notable import duties. This has resulted in higher production costs and potential delays in device availability. On the positive side, tariffs have encouraged local manufacturing, innovation in cost-efficient device designs, and investment in domestic production capabilities.
The temporary mechanical circulatory support device market research report is one of a series of new reports that provides temporary mechanical circulatory support device market statistics, including temporary mechanical circulatory support device industry global market size, regional shares, competitors with a temporary mechanical circulatory support device market share, detailed temporary mechanical circulatory support device market segments, market trends and opportunities, and any further data you may need to thrive in the temporary mechanical circulatory support device industry. This temporary mechanical circulatory support device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A temporary mechanical circulatory support (MCS) device is a specialized medical tool designed to provide short-term assistance to the heart’s pumping function in patients with acute cardiac dysfunction or failure. It mechanically enhances blood flow and stabilizes hemodynamics until recovery, transplantation, or a more permanent intervention can be undertaken. These devices are primarily used in critical care settings to support patients during high-risk cardiac procedures, manage cardiogenic shock, or serve as a bridge to heart transplantation or durable ventricular assist device implantation.
The main categories of temporary mechanical circulatory support devices include left ventricular support devices, right ventricular support devices, and biventricular support devices. Left ventricular support devices assist or replace the pumping function of the left ventricle to maintain adequate blood flow in patients with heart failure. These devices utilize various technologies such as pneumatic systems, mechanical pumps, biomimetic devices, hybrid systems, and emerging wearable solutions. Their applications include managing cardiogenic shock, bridging to transplantation, bridging to recovery, supporting high-risk cardiac procedures, and others. Key end-users comprise hospitals, cardiac surgery centers, outpatient surgical facilities, research and academic institutions, and other healthcare organizations.
The temporary mechanical circulatory support device market consists of sales of intra-aortic balloon pump, extracorporeal membrane oxygenation device, percutaneous ventricular assist device, and centrifugal pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Temporary Mechanical Circulatory Support Device Market Characteristics
3. Temporary Mechanical Circulatory Support Device Market Supply Chain Analysis
4. Global Temporary Mechanical Circulatory Support Device Market Trends and Strategies
5. Temporary Mechanical Circulatory Support Device Market Analysis of End Use Industries
7. Global Temporary Mechanical Circulatory Support Device Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Temporary Mechanical Circulatory Support Device Total Addressable Market (TAM) Analysis for the Market
9. Temporary Mechanical Circulatory Support Device Market Segmentation
10. Temporary Mechanical Circulatory Support Device Market Regional and Country Analysis
11. Asia-Pacific Temporary Mechanical Circulatory Support Device Market
12. China Temporary Mechanical Circulatory Support Device Market
13. India Temporary Mechanical Circulatory Support Device Market
14. Japan Temporary Mechanical Circulatory Support Device Market
15. Australia Temporary Mechanical Circulatory Support Device Market
16. Indonesia Temporary Mechanical Circulatory Support Device Market
17. South Korea Temporary Mechanical Circulatory Support Device Market
18. Taiwan Temporary Mechanical Circulatory Support Device Market
19. South East Asia Temporary Mechanical Circulatory Support Device Market
20. Western Europe Temporary Mechanical Circulatory Support Device Market
21. UK Temporary Mechanical Circulatory Support Device Market
22. Germany Temporary Mechanical Circulatory Support Device Market
23. France Temporary Mechanical Circulatory Support Device Market
24. Italy Temporary Mechanical Circulatory Support Device Market
25. Spain Temporary Mechanical Circulatory Support Device Market
26. Eastern Europe Temporary Mechanical Circulatory Support Device Market
27. Russia Temporary Mechanical Circulatory Support Device Market
28. North America Temporary Mechanical Circulatory Support Device Market
29. USA Temporary Mechanical Circulatory Support Device Market
30. Canada Temporary Mechanical Circulatory Support Device Market
31. South America Temporary Mechanical Circulatory Support Device Market
32. Brazil Temporary Mechanical Circulatory Support Device Market
33. Middle East Temporary Mechanical Circulatory Support Device Market
34. Africa Temporary Mechanical Circulatory Support Device Market
36. Temporary Mechanical Circulatory Support Device Market Competitive Landscape and Company Profiles
37. Temporary Mechanical Circulatory Support Device Market Other Major and Innovative Companies
40. Temporary Mechanical Circulatory Support Device Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Temporary Mechanical Circulatory Support Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses temporary mechanical circulatory support device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for temporary mechanical circulatory support device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The temporary mechanical circulatory support device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Left Ventricular Support Devices; Right Support Devices; Biventricular Support Devices2) By Technology: Pneumatic Devices; Mechanical Pumps; Biomimetic Devices; Hybrid Systems; Novel Wearable Devices
3) By Application: Cardiogenic Shock; Bridge To Transplantation; Bridge To Recovery; High-Risk Cardiac Procedures; Other Applications
4) By End User: Hospitals; Cardiac Surgery Centers; Outpatient Surgical Facilities; Research And Academic Institutions; Other End-Users
Subsegments:
1) By Left Ventricular Support Devices: Intra-Aortic Balloon Pump; Percutaneous Ventricular Assist Device; Extracorporeal Membrane Oxygenation2) By Right Support Devices: Right Ventricular Assist Device; Extracorporeal Membrane Oxygenation; Percutaneous Right Ventricular Assist Device
3) By Biventricular Support Devices: Biventricular Assist Device; Temporary Total Artificial Heart; Extracorporeal Membrane Oxygenation
Companies Mentioned: Abbott Laboratories; Medtronic Plc; Boston Scientific Corporation; Terumo Corporation; Getinge AB; LivaNova PLC; Magenta Medical Ltd.; CorWave SA; Procyrion Inc.; CardioBridge GmbH; Abiomed Inc.; Berlin Heart GmbH; Thoratec Corporation; PulseCath BV; TandemLife Inc.; SynCardia Systems LLC; CardiacAssist Inc.; Xenios AG; Nihon Kohden Corporation; Eurosets Srl; Senko Medical Instrument Manufacturing Co Ltd; Nipro Medical Corporation; Calon Cardio‑Technology Ltd.; Windmill Cardiovascular Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Temporary Mechanical Circulatory Support Device market report include:- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corporation
- Terumo Corporation
- Getinge AB
- LivaNova PLC
- Magenta Medical Ltd.
- CorWave SA
- Procyrion Inc.
- CardioBridge GmbH
- Abiomed Inc.
- Berlin Heart GmbH
- Thoratec Corporation
- PulseCath BV
- TandemLife Inc.
- SynCardia Systems LLC
- CardiacAssist Inc.
- Xenios AG
- Nihon Kohden Corporation
- Eurosets Srl
- Senko Medical Instrument Manufacturing Co Ltd
- Nipro Medical Corporation
- Calon Cardio‑Technology Ltd.
- Windmill Cardiovascular Systems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.9 Billion |
| Forecasted Market Value ( USD | $ 4.1 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
